Sulfasalazine
| Code | Size | Price |
|---|
| TAR-T0907-500mg | 500mg | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T0907-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T0907-1g | 1g | £113.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Sulfasalazine is a synthetic salicylic acid derivative with affinity for connective tissues containing elastin and formulated as a prodrug
CAS:
599-79-1
Formula:
C18H14N4O5S
Molecular Weight:
398.39
Pathway:
Neuroscience; Apoptosis; NF-κb; Autophagy; Microbiology/Virology; Immunology/Inflammation; Cell Cycle/Checkpoint
Purity:
0.9928
SMILES:
OC(=O)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1
Target:
Apoptosis; Ferroptosis; NF-κB; COX; Antibacterial; Antibiotic; Autophagy
References
1. Gadangi P, et al. J Immunol,1996, 156(5), 1937-1941.
2. Liptay S, et al. Br J Pharmacol,1999, 128(7), 1361-1369.
3. Chung WJ, et al. J Neurochem,2009, 110(1), 182-193.
4. Wang Y, Wang S, Xin Y, et al. Hydrogen sulfide alleviates the anxiety-like and depressive-like behaviors of type 1 diabetic mice via inhibiting inflammation and ferroptosis[J]. Life Sciences. 2021: 119551.
5. Lu Y, Yang Q, Su Y, et al. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma[J]. Cell Death & Disease. 2021, 12(6): 1-14.